- Home
- LBRT vs DYN Comparison
LBRT vs DYN Comparison
Compare LBRT & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBRT
- DYN
- Stock Information
- Founded
- LBRT 2011
- DYN 1984
- Country
- LBRT United States
- DYN United States
- Employees
- LBRT N/A
- DYN N/A
- Industry
- LBRT Oilfield Services/Equipment
- DYN Medicinal Chemicals and Botanical Products
- Sector
- LBRT Energy
- DYN Health Care
- Exchange
- LBRT Nasdaq
- DYN Nasdaq
- Market Cap
- LBRT 1.8B
- DYN 1.9B
- IPO Year
- LBRT 2018
- DYN 2020
- Fundamental
- Price
- LBRT $12.93
- DYN $14.51
- Analyst Decision
- LBRT Hold
- DYN Strong Buy
- Analyst Count
- LBRT 9
- DYN 14
- Target Price
- LBRT $15.50
- DYN $34.93
- AVG Volume (30 Days)
- LBRT 4.3M
- DYN 2.5M
- Earning Date
- LBRT 10-16-2025
- DYN 11-11-2025
- Dividend Yield
- LBRT 2.50%
- DYN N/A
- EPS Growth
- LBRT N/A
- DYN N/A
- EPS
- LBRT 1.30
- DYN N/A
- Revenue
- LBRT $4,102,134,000.00
- DYN N/A
- Revenue This Year
- LBRT N/A
- DYN N/A
- Revenue Next Year
- LBRT N/A
- DYN N/A
- P/E Ratio
- LBRT $9.86
- DYN N/A
- Revenue Growth
- LBRT N/A
- DYN N/A
- 52 Week Low
- LBRT $9.50
- DYN $6.36
- 52 Week High
- LBRT $23.58
- DYN $35.90
- Technical
- Relative Strength Index (RSI)
- LBRT 61.41
- DYN 59.18
- Support Level
- LBRT $12.61
- DYN $12.43
- Resistance Level
- LBRT $13.51
- DYN $14.27
- Average True Range (ATR)
- LBRT 0.56
- DYN 0.73
- MACD
- LBRT 0.09
- DYN 0.04
- Stochastic Oscillator
- LBRT 74.16
- DYN 85.53
About LBRT Liberty Energy Inc.
Liberty Energy Inc is a integrated energy services and technology company focused on providing hydraulic fracturing services and related technologies to onshore oil and natural gas exploration and production (E&P) companies. The Company offers customers with hydraulic fracturing services, together with complementary services including wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods (including sand mine operations), and technologies to facilitate lower emission completions, thereby helping customers reduce emissions profile. The company provides services across USA and Canada.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.